We have developed an innovative proprietary platform technology for sustained release of drugs given by injection (the Plexis platform).  This platform may be used for the depot delivery of a broad range of drugs.  Auritec’s Plexis technology combines a membrane based, diffusion-driven release mechanism with drug particle sizing large enough to allow high drug loading, but small enough to be injected. Conceptually, we have developed an injectable depot made up of thousands of biodegradable “mini-Norplants.” We thus combine the benefits of linearization of release with those of injectability. The polymers chosen for the membrane are stable over the projected time of drug delivery and yet ultimately biodegradable. Auritec currently has broad patents pending for this technology.